Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00067587 · ClinicalTrials.gov registry record
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
A clinical trial of HIV Infections and Hypercholesterolemia, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 300
- Enrollment target
- 11
- Study locations
NCT00067587: Completed study of HIV Infections and Hypercholesterolemia, sponsored by University of North Carolina, Chapel Hill.
NCT00067587 is a study of HIV Infections and Hypercholesterolemia that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 300 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (33% lower). The trial reports 11 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00067587, a study of HIV Infections and Hypercholesterolemia, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
- 11
- Study locations
Study Summary
Though anti-HIV drugs can dramatically improve the health of people with HIV, some people taking these drugs develop serious long term effects in their metabolism. These effects include problems with bones, increased levels of blood sugar and lipids, and changes in body fat distribution. The purpose of this study is to see how many young women are experiencing these problems and how severe the problems are. This kind of study is the first step in determining how best to treat these problems.
Conditions Studied
Study Locations (11)
Florida
- Children's Diagnostic and Treatment Center - Fort Lauderdale
- University of Miami - Miami
- University of South Florida - Tampa
California
- Children's Hopsital of Los Angeles - Los Angeles
- University of California at San Diego - San Diego
New York
- Mt. Sinai Hospital - New York
- Montefiore Medical Center - The Bronx
District of Columbia
- Children's National Medical Center - Washington D.C.
Illinois
- Stoger Hospital of Cook County - Chicago
Louisiana
- Tulane University - New Orleans
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2003-07 |
| Est. Completion | 2005-06 |
What the finished NCT00067587 record still lists
NCT00067587 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (33% lower).
The record links to 3 conditions, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.
NCT00067587 lists 11 locations in 7 states (Florida, California, New York).
Frequently Asked Questions
What is clinical trial NCT00067587 about?
NCT00067587 is a clinical study titled "Metabolic Abnormalities in HIV Infected and Uninfected Young Women". Though anti-HIV drugs can dramatically improve the health of people with HIV, some people taking these drugs develop serious long term effects in their metabolism. These effects include problems with bones, increased levels of blood sugar and lipids, and changes in body fat distribution. The purpose...
What is the current status of trial NCT00067587?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2003-07. Estimated completion is 2005-06.
What conditions does trial NCT00067587 study?
This clinical trial studies the following conditions: HIV Infections, Hypercholesterolemia, Glucose Intolerance.
Who is sponsoring clinical trial NCT00067587?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00067587 being conducted?
This trial has 11 study locations across California, District of Columbia, Florida, Illinois, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00067587's enrollment target sits among peer trials
300 115th of 542 higher than 417 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia